Phase II Study of Histone Deacetylase Inhibitor SAHA (Vorinostat) in Patients With Metastatic Thyroid Carcinoma
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2013
At a glance
- Drugs Vorinostat (Primary)
- Indications Head and neck cancer; Thyroid cancer
- Focus Therapeutic Use
- 17 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 07 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2007 Status changed from suspended to in progress.